Nutriband Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Nutriband Inc. (Nasdaq: NTRB) on May 16, 2024, covering events occurring on May 15, 2024. The company is incorporated in Nevada and maintains its principal executive offices in Orlando, Florida. Nutriband is classified as an emerging growth company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The primary material change reported is the appointment of a new director to the Board of Directors.
- Item 5.02: On May 15, 2024, the Board appointed Sergei Glinka as a director.
- Background: Mr. Glinka, age 58, has served as Commercial Manager of TG Biochemicals Limited (Cyprus) since 2019 and as a Board member of GST Investments OÜ (Estonia) since 2019.
- Education: He graduated from the Tallinn Merchant Marine School in 1986.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, specific risks, contingencies, or unusual items. The report is limited to the disclosure of the director appointment.
Investor Verification Checklist
- Verify the biographical details and potential conflicts of interest for the newly appointed director, Sergei Glinka.
- Confirm the current composition of the Board of Directors following this appointment.
- Review the company's most recent 10-Q or 10-K filings for the latest financial metrics, as this 8-K contains no financial data.
- Monitor subsequent filings for any compensatory arrangements related to the new director, if applicable.